Balance Sheet Data

Emergent BioSolutions Inc. (EBS)

$35.33

+3.64 (+11.49%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 178.29112.20167.80621.30576.10641.71861.091,155.471,550.492,080.54
Total Cash (%)
Account Receivables 146.08271.10275.30230.90274.70556.91747.301,002.781,345.601,805.61
Account Receivables (%)
Inventories 142.81205.80222.50307350.80534.95717.83963.231,292.521,734.39
Inventories (%)
Accounts Payable 41.7580.7094.80136.10128.90203.37272.89366.18491.37659.35
Accounts Payable (%)
Capital Expenditure -54.83-72.10-86.90-141-225-233.17-312.88-419.84-563.37-755.96
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.